| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.063 | 0.2 |